Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bryskier

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
Pathologie-Biologie|June 1, 1988
[Interaction of roxithromycin with human polymorphonuclear neutrophils in vitro and ex vivo]M T Labro, A Bryskier, C Babin-Chevaye, et al.
Pathologie-Biologie|June 1, 1984
[Pharmacokinetic behavior of cefsulodin and cefotiam alone or in combination after intravenous injection of 1 gram]J B Fourtillan, A Bryskier, M A Lefebvre, et al.
Pathologie-Biologie|June 1, 1985
[RU 28965, a new semi-synthetic macrolide. Bioavailability and pharmacokinetic profile after oral administration]D Tremblay, A Bryskier, M Vuckovic, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1990
Pharmacokinetics of cefodizime administered intravenously as a single-dose (1.0 and 2.0 g) to healthy adult volunteersA Bryskier, T Procyk, D Tremblay, et al.
Pathologie-Biologie|May 1, 1984
[HPLC study of the inhibition of enterobacterial cephalosporinases by cefmenoxime]A Pechinot, J M Duez, A Bryskier, et al.
Pathologie-Biologie|December 1, 1986
[Pharmacokinetics of cefmenoxime in the aged subject (60 to 90 years of age) after an intravenous injection of 1 g]P Veyssier, A Bryskier, J Modai, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1990
The pharmacokinetics of cefodizime following intravenous and intramuscular administration of a single dose of 1.0 gA Bryskier, T Procyk, D Tremblay, et al.
The Journal of Antimicrobial Chemotherapy|March 17, 2001
The bactericidal activities of HMR 3004, HMR 3647 and erythromycin against gram-positive bacilli and development of resistanceR Fernández-Roblas, R Calvo, J Esteban, et al.
The Journal of Antimicrobial Chemotherapy|February 1, 1997
Bactericidal activity of cefodizime on Enterobacteriaceae in an in-vitro model simulating plasma pharmacokinetics in humansA Péchinot, C Neuwirth, A Bryskier, et al.
Zentralblatt Fur Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology|August 1, 1984
Combination effect of cefmenoxime with four aminoglycosides on Enterobacteriaceae susceptible and moderately susceptible to this new cephalosporinM O Husson, D Izard, A Bryskier, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Pathologie-Biologie|June 1, 1988
[Interaction of roxithromycin with human polymorphonuclear neutrophils in vitro and ex vivo]M T Labro, A Bryskier, C Babin-Chevaye, et al.
Pathologie-Biologie|June 1, 1984
[Pharmacokinetic behavior of cefsulodin and cefotiam alone or in combination after intravenous injection of 1 gram]J B Fourtillan, A Bryskier, M A Lefebvre, et al.
Pathologie-Biologie|June 1, 1985
[RU 28965, a new semi-synthetic macrolide. Bioavailability and pharmacokinetic profile after oral administration]D Tremblay, A Bryskier, M Vuckovic, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1990
Pharmacokinetics of cefodizime administered intravenously as a single-dose (1.0 and 2.0 g) to healthy adult volunteersA Bryskier, T Procyk, D Tremblay, et al.
Pathologie-Biologie|May 1, 1984
[HPLC study of the inhibition of enterobacterial cephalosporinases by cefmenoxime]A Pechinot, J M Duez, A Bryskier, et al.
Pathologie-Biologie|December 1, 1986
[Pharmacokinetics of cefmenoxime in the aged subject (60 to 90 years of age) after an intravenous injection of 1 g]P Veyssier, A Bryskier, J Modai, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1990
The pharmacokinetics of cefodizime following intravenous and intramuscular administration of a single dose of 1.0 gA Bryskier, T Procyk, D Tremblay, et al.
The Journal of Antimicrobial Chemotherapy|March 17, 2001
The bactericidal activities of HMR 3004, HMR 3647 and erythromycin against gram-positive bacilli and development of resistanceR Fernández-Roblas, R Calvo, J Esteban, et al.
The Journal of Antimicrobial Chemotherapy|February 1, 1997
Bactericidal activity of cefodizime on Enterobacteriaceae in an in-vitro model simulating plasma pharmacokinetics in humansA Péchinot, C Neuwirth, A Bryskier, et al.
Zentralblatt Fur Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology|August 1, 1984
Combination effect of cefmenoxime with four aminoglycosides on Enterobacteriaceae susceptible and moderately susceptible to this new cephalosporinM O Husson, D Izard, A Bryskier, et al.
Pageof 11